[1]Gibson J F, Johnston S A. Immunity to Cryptococcus neoformansand C.gattii during cryptococcosis[J]. Fungal Genet Biol, 2015, 78:76–86.
[2]Xu J, Eastman A J, Flaczyk A, et al. Disruption of early tumor necrosis dactor alpha signaling prevents classic alactivation of dendritic cells in lung-associated lymph nodes and development of protective immunity against cryptococcal infection [J]. MBio, 2016, 7 (4): e00510–00516.
[3]Brown G D, Denning D W, Levitz S M. Tackling human fungal infections[J]. Sci, 2012, 336(6082):647.
[4]Fang W, Fa Z, Liao W. Epidemiology of Cryptococcus and cryptococcosis in China[J]. Fungal Genet Biol, 2015,78:7–15.
[5]Yoo SD, Worodria W, Med M, The prevalence and clinical course of HIV-associated pulmonary cryptococcosis in Uganda[J]. J Acquir Immune Defic Syndr 2010; 54:269–74.
[6]Jarvis JN, Wainwright H, Harrison TS, Pulmonary cryptococcosis misdiagnosed as smear-negative pulmonary tuberculosis with fatal consequences[J]. Int J Infect Dis 2010;14S:e310–12.
[7]Brizendine KD, Baddley JW, Pappas PG. Pulmonary cryptococcosis[J]. Semin Respir Crit Care Med 2011;32:727–34.
[8]Kozel T R, Bauman S K. CrAg lateral flow assay for cryptococcosis[J]. Expert opinion on medical diagnostics, 2012, 6(3): 245–251.
[9]Drain P K, Hong T, Krows M, et al. Validation of clinic-based cryptococcal antigen lateral flow assay screening in HIV-infected adults in South Africa[J]. Sci. Rep, 2019, 9(1).
[10]Mcmullan B J, Catriona H, Sorrell T C, et al. Clinical Utility of the Cryptococcal Antigen Lateral Flow Assay in a Diagnostic Mycology Laboratory[J]. PLoS ONE, 2012, 7(11):e49541.
[11]Lan W, Yong Z, Xian-tao Z. The QUADAS–2 Tool for the Quality Assessment of Diagnostic Accuracy Study:an Introduction[J]. J Hub Uni Med, 2013, 32(03):201–208.
[12]Lindsley M D, Mekha N, Baggett H C, et al. Evaluation of a Newly Developed Lateral Flow Immunoassay for the Diagnosis of Cryptococcosis[J]. Clin Inf Dis, 2011, 53(4):321–325.
[13]Binnicker M J, Jespersen D J, Bestrom J E, Rollins LO. Comparison of Four Assays for the Detection of Cryptococcal Antigen[J]. Clin Vac Immunol, 2012, 19(12): 1988–1990.
[14]Escandón, Patricia, Lizarazo J, Agudelo C I, et al. Evaluation of a rapid lateral flow immunoassay for the detection of cryptococcal antigen for the early diagnosis of cryptococcosis in HIV patients in Colombia[J]. Med Mycol, 2013, 51(7): 765–768.
[15]Hansen J, Slechta E S, Gates-Hollingsworth M A, et al. Large-Scale Evaluation of the Immuno-Mycologics Lateral Flow and Enzyme-Linked Immunoassays for Detection of Cryptococcal Antigen in Serum and Cerebrospinal Fluid[J]. Clin Vac Immunol, 2013, 20(1):52–55.
[16]Rugemalila J, Maro V P, Kapanda G, et al. Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay[J]. Trop Med Int Health, 2013, 18(9): 1075–1079.
[17]Boulware D R, Rolfes M A, Rajasingham R, et al. Multisite Validation of Cryptococcal Antigen Lateral Flow Assay and Quantification by Laser Thermal Contrast[J]. Emerg Inf Dis, 2014, 20(1):45–53.
[18]Lourens A, Jarvis J N, Meintjes G, et al. Rapid Diagnosis of Cryptococcal Meningitis by Use of Lateral Flow Assay on Cerebrospinal Fluid Samples: Influence of the High-Dose “Hook” Effect[J]. J. Clin Microbiol, 2014, 52(12): 4172–4175.
[19]Diane Rivet-Dañon, Guitard J, Grenouillet, Frédéric, et al. Rapid diagnosis of cryptococcosis using an antigen detection immunochromatographic test[J]. J Inf, 2015, 70(5):499–503.
[20]Suwantarat N, Dalton J B, Lee R, et al. Large-scale clinical validation of a lateral flow immunoassay for detection of cryptococcal antigen in serum and cerebrospinal fluid specimens[J]. Diagnostic Microbiol Inf Dis, 2015, 82(1):54–56.
[21]Jitmuang A, Panackal A A, Williamson P R, et al. Performance of the Cryptococcal Antigen Lateral Flow Assay in Non-HIV Related Cryptococcosis[J]. J clin microbiol, 2015, 54(2):460–463.
[22]Cáceres Diego H, Alejandra Z, Tabares ángela M, et al. Evaluation of a Cryptococcal antigen Lateral Flow Assay in serum and cerebrospinal fluid for rapid diagnosis of cryptococcosis in Colombia[J]. Rev Do Ins Med Trop São Paulo, 2017, 59(0):e76.
[23]Frola C, Guelfand L, Blugerman G, et al. Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay[J]. PloS One, 2017, 12(6):e0178721.
[24]Elvis T, Charles K, Leonella M, et al. Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test[J]. Fron Microbiol, 2018, 9:409.